Status:
COMPLETED
Neurocognitive Training Integrated in OPUS Treatment Versus OPUS Treatment-as-usual
Lead Sponsor:
Neurocom
Conditions:
Schizophrenia
Eligibility:
All Genders
18-35 years
Phase:
PHASE3
Brief Summary
The study examines the effect of cognitive training on cognitive functioning and everyday competencies of patients with schizophrenia. 120 patients are expected to be included in this randomized cont...
Detailed Description
Neurocognition and competence in schizophrenia A randomized controlled trial of cognitive training (CT) integrated in OPUS treatment versus OPUS treatment-as-usual The presence of cognitive deficits ...
Eligibility Criteria
Inclusion
- Age between 18-35 years,
- First-episode schizophrenia og schizotypal disorder in ICD-10,
- Post-acute phase of illness,
- Sufficient comprehension of Danish,
- Written informed consent
Exclusion
- Rejection of participation,
- Organic disorder,
- Misuse of psychoactive drugs
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
117 Patients enrolled
Trial Details
Trial ID
NCT00472862
Start Date
January 1 2007
End Date
April 1 2010
Last Update
April 15 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bispebjerg University Hospital
Copenhagen, Denmark, 2400